Alzheimer’s Disease Care

At NY Neurology Associates, our experienced neurologists specialize in the diagnosis and comprehensive management of Alzheimer’s disease. Contact us today to schedule a thorough evaluation and take the first step toward understanding your symptoms and protecting your cognitive health.

Alzheimer’s disease is a complex neurological condition that requires more than a one-size-fits-all approach to care. In this article, you’ll learn how comprehensive evaluation, advanced treatment options, and innovative research are shaping modern Alzheimer’s disease management.

If you or a loved one is experiencing memory concerns in New York, early evaluation can make a meaningful difference. Contact New York Neurology Associates today to schedule a comprehensive consultation and receive personalized, research-driven care.

Understanding Alzheimer’s Disease

Alzheimer’s disease is a complex neurodegenerative condition that leads to progressive memory loss and cognitive decline. While it has long been associated with the buildup of abnormal proteins—such as amyloid plaques and tau tangles—the true disease process is far more intricate.

Modern research suggests that Alzheimer’s likely develops from a combination of factors, including genetics, inflammation, vascular changes, and metabolic dysfunction. Although amyloid buildup is one component, scientists now understand that multiple biological pathways contribute to nerve cell damage and brain atrophy over time.

At New York Neurology Associates, we approach Alzheimer’s care with this complexity in mind. Our goal is to offer personalized, research-informed care—combining early diagnosis, evidence-based treatment, and access to new therapies that address the disease from multiple angles.

Comprehensive Evaluation and Diagnostic Protocol

Accurate and early diagnosis is essential to guide effective treatment and long-term planning. 

Each patient may undergo:

  • Memory and Cognitive Testing – Formal neurocognitive assessments to evaluate memory, attention, language, and problem-solving skills.
  • EEG (Electroencephalogram) – To assess brain activity and rule out seizures or other neurological causes of cognitive change.
  • MRI or PET Scan – Advanced neuroimaging to assess brain structure and function, identify patterns of atrophy, and detect amyloid or tau-related changes.
  • Laboratory Testing –  Blood and metabolic panels to rule out reversible causes of memory loss, including thyroid, vitamin, or metabolic disorders.
  • Neuropsychological Testing Referral – When needed, we coordinate comprehensive neuropsychological testing to better define the type and extent of cognitive impairment.
 

Through this integrated approach, our physicians can distinguish between Alzheimer’s disease, vascular dementia, Lewy body dementia, frontotemporal dementia, and other cognitive disorders—ensuring the most accurate diagnosis and individualized treatment plan.

Advanced and Emerging Treatment Options

New York Neurology Associates offers access to the latest FDA-approved, disease-modifying therapies for Alzheimer’s disease, including:

  • Leqembi (lecanemab)
  • Kisunla (donanemab)

These treatments are designed to target amyloid buildup in the brain and may help slow cognitive decline when initiated early in the disease process.

However, our physicians recognize that amyloid is only one part of the story. Ongoing research continues to explore the roles of tau protein, inflammation, oxidative stress, mitochondrial dysfunction, and cerebrovascular health in Alzheimer’s disease progression.

Our neurologists provide individualized recommendations that may include:

  • Cognitive and lifestyle interventions to support brain health
  • Management of comorbidities such as hypertension, diabetes, and sleep apnea
  • Nutritional and physical activity counseling
  • Clinical trial enrollment when appropriate

Research and Clinical Trials

Alzheimer’s research is evolving rapidly, and new approaches are showing genuine promise. At New York Neurology Associates, we are actively involved in clinical research exploring emerging therapies aimed at multiple biological targets—not only amyloid, but also tau, inflammation, and neurovascular health.

Eligible patients may be able to participate in clinical trials that provide early access to investigational treatments under close medical supervision.

Schedule an Alzheimer’s Evaluation in New York

Early diagnosis and individualized treatment planning are essential in managing Alzheimer’s disease effectively. At New York Neurology Associates, our neurologists provide advanced diagnostic testing, access to the latest therapies, and participation in clinical trials when appropriate. 

Call our office in New York, NY, today to schedule an appointment and take the next step toward expert, compassionate Alzheimer’s care.

Our General Neurology Providers

Related Blogs

No more posts to show

Feedback From our Patients

Choose your preferred location

7 Gramercy Park West Lower Level New York, NY 10003
2965 Long Beach Road Suite 200 Oceanside, NY 11572

Loading...